5
1
H NMR (400 MHz, DMSO-d
.09–2.03 (m, 2H), 1.94–1.82 (m, 1H), 0.91–0.90 (d, J = 6.4, 6H) ppm; C
6
): δ 12.37 (s, 1H), 6.92–6.88 (t, J = 7.3, 1H),
50.0%, Pale yellow
liquid, 94.32%
1
3
2
3
1
NMR (400 MHz, DMSO-d ): 167.63, 165.92, 136.06, 126.04, 70.89, 40.24,
6
6
i
2
7.55, 25.50 (2C) ppm; ESI-MS: m/z 186.05 (M+1).
1
H NMR (400 MHz, DMSO-d ): δ 12.36 (s, 1H), 6.91–6.87 (t, J = 7.3, 1H),
6
3
1
2.10 (m, 2H), 1.22–1.40 (m, 2H), 1.12–1.20 (m, 2H), 0.90 (t, J = 7.4, 3H)
50.0%, Yellow liquid,
90.53%
6
7
j
13
ppm; C NMR (400 MHz, DMSO-d
6
): 167.59, 165.97, 137.3, 127.79, 40.0,
3
0.90, 21.74, 13.59 ppm; ESI-MS: m/z 186.99 (M+1).
1
H NMR (400 MHz, DMSO-d
6
): δ 8.39 (s, 1H), 7.98–7.96 (d, J = 8.8, 2H),
57.7%, Off-white solid,
97.61%
7
.18–7.16 (d, J = 8.8, 2H), 4.18–4.16 (m, 2H), 1.37–1.34 (t, J = 7.4, 3H)
13
ppm; C NMR (400 MHz, DMSO-d
6
): 163.68, 160.43, 133 (2C), 123.95,
1
15.5, 76.63, 64.04, 14.34 ppm; ESI-MS: m/z 217 (M+19).
2
2
2. Ragan, J. A.; am Ende, D. J.; Brenek, S. J.; Eisenbeis, S. A.;
Singer, R. A.; Tickner, D. L.; Teixeira, J. T., Jr.; Vanderplas, B.
C.; Weston, N. Org. Process Res. Dev. 2003, 7, 155−160.
3. A Scifinder® search from 1886 to present-day showed 114 articles
on the various roles of the bisulfite adduct of benzaldehyde; only
two of those articles were on carbon-carbon bond formation.
Acknowledgements
We are thankful to the management of Dr. Reddy’s
Laboratories Ltd., for giving support to carry out our work. We
are also thankful to our colleagues in analytical and process
research for their collaboration.
24. Kjell, D. P.; Slattery, B. J.; Semo, M. J. J. Org. Chem. 1999, 64,
5
722-5724.
2
2
5. Cong, C.; Wang, H.; Hu, Y.; Liu, C.; Ma, S.; Li, X.; Ma, S. Eur. J.
Med. Chem. 2011, 46, 3105-3111.
6. Mohanty, S.; Reddy, S. G.; Karmakar, A. C. Lett. Org. Chem.
2014, 11, 197–202.
References and notes
1
2
.
.
Ricardo, M. In Green Chemistry – Environmentally Benign
Approaches; Kidwai, M., Ed.; InTech: Shanghai, 2012, pp 13-32.
Harrington, P. J. Pharmaceutical Process Chemistry for
Synthesis: Rethinking the Routes to Scale-Up, John Wiley & Sons:
Hoboken, 2011.
27. Mobile phase: ethyl acetate and petroleum ether (3:7). Sample
preparation: take reaction mass and dilute with diluents methanol
and dichloromethane (1:1).
th
28. Montgomery, D. C. Design and Analysis of Experiments: 7 ed.,
3
4
.
.
Krishna, S. R.; Rao, M. V. N. B.; Raju, T. S.; Himabindu, V.;
Reddy, G. M. E-J. Chem. 2008, 5, 562-566.
Madivada, L. R.; Anumala, R. R.; Gilla, G.; Alla, S.; Charagondla,
K.; Kagga, M.; Bhattacharya, A.; Bandichhor, R.; Org. Progress
Res. Dev. 2009, 13, 1190-1194.
Beutler, U.; Fuenfschilling, P. C.; Steinkemper, A. Org. Process
Res. Dev. 2007, 11, 341–345.
Mukarram, S. M. J.; Khan, R. A. R.; Yadav, R. P. U.S. Patent
John Wiley & Sons: Hoboken, 2009.
29. Significant variables will have p-values <0.05 at the 95%
confidence interval.
30. (a) Momose, Y.; Meguro, K.; Ikeda, H.; Hatanaka, C.; Oi, S.;
Sodha, T. Chem. Pharm. Bull. 1991, 39, 1440–1445. (b) Pratap, U.
R.; Jawale, D. V.; Waghmare, R. A.; Lingampalle, D. L.; Mane,
R. A. New J. Chem. 2011, 35, 49–51. (c) Pascual, C.; Meier, J.;
Simon, W. Helv. Chim. Acta 1966, 49, 164–168.
31. General procedure for the condensation of the aliphatic bisulfite
adduct of aldehydes with 2,4-thiazolidinedione. The bisulfite
adduct of aliphatic aldehydes such as sodium 1-hydroxy-4-
methylpentane-1-sulfonate/sodium 1-hydroxypentane-1-sulfonate
was taken with active methylene compounds such as 2,4-
thiazolidinedione/malononitrile as described in the experimental
section to afford compounds 6i–j and 7. Purified through column
by using silica gel (Mesh 100–200, eluting with 5%, 10%, and
15% ethyl acetate in hexane) to obtain title compounds.
5
6
7
.
.
.
2
007/0004, 935, 2007.
(a) Jain, V. S.; Vora, D. K.; Ramaa, C. S. Bioorg. Med.
Chem. 2013, 21, 1599-1620. (b) Chen, H.; Fan, Y.-H.; Natarajan,
A.; Guo, Y.; Iyasere, J.; Harbinski, F.; Luus, L.; Christ, W.; Aktas,
H.; Halperin, J. A. Bioorg. Med. Chem. Lett. 2004, 14, 5401-5405.
Oguchi, M.; Wada, K.; Honma, H.; Tanaka, A.; Kaneko, T.;
Sakakibara, S.; Ohsumi, J.; Serizawa, N.; Fujiwara, T.; Horikoshi,
H.; Fujita, R. J. Med. Chem. 2000, 43, 3052–3066.
Ma, L.; Xie, C.; Ma, Y.; Liu, J.; Xian, M.; Ye, X.; Zheng, H.;
Chen, Z.; Xu, Q.; Chen, T.; Chen, J.; Yang, J.; Qiu, N.; Wang, G.;
Liang, X.; Peng, A.; Yang, S.; Wei, Y.; Chen, L. J. Med. Chem.
8
9
.
.
32. General procedure for the condensation of the bisulfite adduct of
aldehydes with 2,4-thiazolidinedione. The bisulfite adduct of
3
3
2
011, 54, 2060–2068.
aromatic aldehydes (2a–h, 39.40 mmol) was taken with 2,4-
thiazolidinedione (3, 39.30 mmol) in toluene (50 mL) in a 100 mL
1
1
0. Wu, Y.; Karna, S.; Choi, C. H.; Tong, M.; Tai, H.-H.; Na, D. H.;
Jang, C. H.; Cho, H. J. Med. Chem. 2011, 54, 5260–5264.
1. Hulin, B.; Clark, D. A.; Goldstein, S. W.; McDermott, R. E.;
Dambek, P. J.; Kappeler, W. H.; Lamphere, C. H.; Lewis, D. M.;
Rizzi, J. P. J. Med. Chem. 1992, 35, 1853–1864.
2. Zidar, N.; Tomašić, T.; Šink, R.; Rupnik, V.; Kovač, A.; Turk, S.;
Patin, D.; Blanot, D.; Martel, C. C.; Dessen, A.; Premru, M. M.;
Zega, A.; Gobec, S.; Mašič, P.; Kikelj, D. J. Med. Chem. 2010, 53,
round bottom flask. Ac O (2.0 g, 0.5 equiv.) was then added in
2
one portion at 55 ºC. The reaction temperature was gradually
raised to 110 ºC and was maintained for 12 h. After the
completion of the reaction, it was slowly quenched into ice water.
The biphasic slurry was allowed to stir below 20 ºC for 10 min
and the precipitated product was filtered using a Buchner funnel.
The wet cake was washed with 2 × 10 mL toluene at 25 ºC and
dried under vacuum at 50 ºC to afford the desired benzylidene-2,4-
thiazolidinedione (6) in good yields.
1
6
584–6594.
1
1
1
3. Rawal, R. K.; Prabhakar, Y. S.; Katti, S. B.; De Clercq, E. Bioorg.
Med. Chem. 2005, 13, 6771-6776.
33. R CHO, 2a–h (R = 4-EtO-C H , 4-MeO-C H , 4-Cl-C H , 2-Cl-
2
2
6
5
6
5
6
5
4. Suster, D. C.; Feyns, L. V.; Ciustea, G.; Botez, G.; Dobre, V.;
Bick, R.; Niculescu-Duvaz, I. J. Med. Chem. 1974, 17, 758–760.
5. Das, J.; Floyd, D. M.; Kimball, S. D.; Duff, K. J.; Lago, M. W.;
Krapcho, J.; White, R. E.; Ridgewell, R. E.; Obermeier, M. T. J.
Med. Chem. 1992, 35, 2610–2617.
6 5 2 6 5 6 5
C H , 4-NO -C H , C H , naphthyl)
1
1
6. Somu, R. V.; Boshoff, H.; Qiao, C.; Bennett, E. M.; Barry, C. E.,
III; Aldrich C. C. J. Med. Chem. 2006, 49, 31–34.
7. (a) Bekbölet, M.; Getoff, N. Int. J. Photoenergy 2002, 4, 133-139.
(
b) van der Beek P. A. A. Recl. Trav. Chim. Pays-Bas 1928,
4
7, 286–300. (c) Bawn, C. E. H.; Jolley, J. E. Proc. R. Soc. Lond.
Ser. A 1956, 237, 297-312.
1
1
2
2
8. Jones, C. W. Applications of Hydrogen Peroxide and Derivatives,
Royal Society of Chemistry: Cambridge, 1999.
9. Liu, Q.; Perreault, S.; Rovis, T. J. Am. Chem. Soc. 2008, 130,
1
4066-14067.
0. March, J. Advanced Organic Chemistry, 4th ed., John Wiley &
Sons (Asia): Singapore, 2005.
1. Spent aqueous acid or base used for deprotection would go to an
effluent treatment plant before being discharged.